IGC Pharma (IGC) Gross Margin (2010 - 2025)
IGC Pharma (IGC) reported Gross Margin of 51.83% for Q3 2025, up 377.0% year-over-year from 10.87% in Q3 2024, and up 10.4% quarter-over-quarter from 46.95% in Q2 2025.
IGC Pharma (IGC) Gross Margin (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has 16 years of Gross Margin data on file, last reported at 51.83% in Q3 2025.
- Gross Margin for Q3 2025 came in at 51.83%, up 377.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 46.2% (down 1001.0% YoY), and the FY2026 annual result was 17.35%, down 3135.0% from the prior year.
- Gross Margin rose to 51.83% in Q3 2025 per IGC's latest filing, from 46.95% in the prior quarter.
- Over five years, Gross Margin peaked at 67.86% in Q3 2021 and troughed at 30.72% in Q4 2022.
- A 5-year average of 50.51% and a median of 48.06% in 2024 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2021 and 2024: Gross Margin jumped 4706 bps in 2021, then slumped 2473 bps in 2024.
- A 5-year view of Gross Margin shows it stood at 43.66% in 2021, then retreated by 30 bps to 30.72% in 2022, then surged by 112 bps to 65.2% in 2023, then tumbled by 38 bps to 40.47% in 2024, then increased by 28 bps to 51.83% in 2025.
- Business Quant data shows IGC's Gross Margin at 51.83% in Q3 2025, 46.95% in Q2 2025, and 46.67% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 79.04% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 86.85% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 51.83% |
| Jun 30, 2025 | 46.95% |
| Mar 31, 2025 | 46.67% |
| Dec 31, 2024 | 40.47% |
| Sep 30, 2024 | 48.06% |
| Jun 30, 2024 | 59.93% |
| Mar 31, 2024 | 57.97% |
| Dec 31, 2023 | 65.20% |
| Sep 30, 2023 | 59.79% |
| Jun 30, 2023 | 45.95% |
| Mar 31, 2023 | 37.95% |
| Dec 31, 2022 | 30.72% |
| Sep 30, 2022 | 66.83% |
| Jun 30, 2022 | 66.98% |
| Mar 31, 2022 | 55.74% |
| Dec 31, 2021 | 43.66% |
| Sep 30, 2021 | 67.86% |
| Jun 30, 2021 | 33.77% |
| Mar 31, 2021 | 33.33% |
| Dec 31, 2020 | 12.96% |